CHI's latest Next-Generation Sequencing meeting takes place in San Diego, March 17-19, 2009. Highlights include a keynote from Richard Gibbs, updates from all the major commercial platforms, and one of the first presentations from Complete Genomics (Rade Drmanac).
Unconfigured Ad
Collapse
X
-
I'm biased (being affiliated with CHI) but the Next-Gen Sequencing meetings are among the best attended, fastest growing events. Yes, there's a strong presence of commercial technology suppliers, but most of the audience likes that -- at least for this topic. With the exception of AGBT, this is one of the best places to get information and network.Kevin Davies
Author, The $1,000 Genome
Comment
-
-
"commercial" nature of the conference is a great feature. For example, in this conference we discovered a new startup which invented technology to perform next gen sequence alignment 100 times faster than any other solution. We don't have the budget for big cluster like some of you big time genome centers. With these guys' tool, we do alignment on one computer, and it cuts our total sample sequencing time by a day. Its nice to hear academics talking about their wonderful science (fiction), but we go to this conference to also pick up the latest technology "real solutions", and for that we need "commercial" vendors. Unfortunately Next Gen sequencing is not main stream enough that we can get the best tools automatically from Microsoft and Intel... no , we rely on small innovative start ups (often formed by professors !!) and the only way we find out about them is these "commercial" shows.
Comment
-
-
BioWizard, again, please see your PM box before posting further about aligners. Thanks!Originally posted by BioWizard View Post"commercial" nature of the conference is a great feature. For example, in this conference we discovered a new startup which invented technology to perform next gen sequence alignment 100 times faster than any other solution. We don't have the budget for big cluster like some of you big time genome centers. With these guys' tool, we do alignment on one computer, and it cuts our total sample sequencing time by a day. Its nice to hear academics talking about their wonderful science (fiction), but we go to this conference to also pick up the latest technology "real solutions", and for that we need "commercial" vendors. Unfortunately Next Gen sequencing is not main stream enough that we can get the best tools automatically from Microsoft and Intel... no , we rely on small innovative start ups (often formed by professors !!) and the only way we find out about them is these "commercial" shows.
Comment
-
-
BioWizard:Originally posted by BioWizard View Post"commercial" nature of the conference is a great feature. For example, in this conference we discovered a new startup which invented technology to perform next gen sequence alignment 100 times faster than any other solution. We don't have the budget for big cluster like some of you big time genome centers. With these guys' tool, we do alignment on one computer, and it cuts our total sample sequencing time by a day. Its nice to hear academics talking about their wonderful science (fiction), but we go to this conference to also pick up the latest technology "real solutions", and for that we need "commercial" vendors. Unfortunately Next Gen sequencing is not main stream enough that we can get the best tools automatically from Microsoft and Intel... no , we rely on small innovative start ups (often formed by professors !!) and the only way we find out about them is these "commercial" shows.
I agree that great collaboration must exist between commercial and academic initiatives. It just sometimes, highly commercial talks just end up being advertisement without much discussion of method/development. I think there are a proliferation of open source efforts within the next generation markets which allows for all players to be involved.
Comment
-
-
Slightly off topic, but CHI is going a bit extra with their marketing.. I feel so especially after I got the pre-recorded Kevin Davies call close to mid-night asking to consider attending BioIT world Expo and networking with 1500 people .. blah..blah..Originally posted by doxologist View PostFor those who have been to CHI meetings... what is your experience? From their millions of advertising emails, I have become a little suspicious of the commercial nature of the conference.--
bioinfosm
Comment
-
-
Small Group Gathering regarding aligners
Hello,
I will be attending the CHI conf in San Diego and for the ones that are interested in aligners I would like to propose a small group discussion in between talks.
Date and time will be determined soon. Will anyone be interested on getting together to share ideas re the storm of aligners and the short read headache we all tend to deal with?
Victor
Comment
-
-
Conference update.
Interesting Panel discussion today.
A representative from Illumina, Roche, Solid and Helicos were all side by side answering questions from the audience.
The common problem was scalability. All four are working on trying to use a little sample as possible (well as Helicos) and make easier to run more samples. Gel/PCR free protocols are on the way.
Have not heard of a GAIII yet from Illumina. I did hear from the 1.4 pipeline.
It supposed to do a better job extracting intensities from images. So, do we save the images after all?
victor
Comment
-
Latest Articles
Collapse
-
by mylaserKheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
This guide explains everything you need to know about...-
Channel: Articles
Today, 01:13 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 07-09-2026, 10:04 AM
|
0 responses
17 views
0 reactions
|
Last Post
by SEQadmin2
07-09-2026, 10:04 AM
|
||
|
Started by SEQadmin2, 07-08-2026, 10:08 AM
|
0 responses
10 views
0 reactions
|
Last Post
by SEQadmin2
07-08-2026, 10:08 AM
|
||
|
Started by SEQadmin2, 07-07-2026, 11:05 AM
|
0 responses
22 views
0 reactions
|
Last Post
by SEQadmin2
07-07-2026, 11:05 AM
|
||
|
Started by SEQadmin2, 07-02-2026, 11:08 AM
|
0 responses
31 views
0 reactions
|
Last Post
by SEQadmin2
07-02-2026, 11:08 AM
|
Comment